Clin2
NCT05732051Possibly a fitRecruiting

Nicotinamide riboside to protect the heart during breast cancer chemo

Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac DysfunctionCardiotoxicityHeart Failure

Treatments studied

Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.

This trial tests whether nicotinamide riboside can help prevent heart problems caused by a common breast-cancer chemotherapy (anthracyclines). If you’re eligible, you’ll be followed to see how your heart is doing during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You’re a woman with stage IV (metastatic) breast cancer
  • You are scheduled to receive chemotherapy that includes anthracyclines
  • You can do most daily activities (performance status 0 to 2)
  • Your expected life expectancy is at least 6 months
  • You’re able to have heart MRI scans (CMR) as part of the study
  • You have no allergy to nicotinamide riboside (Niagen) tablet

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07419711Not yet recruiting
Grape polyphenols to prevent heart damage from chemo

This trial tests whether grape polyphenols can help protect the heart in women being treated for breast cancer with certain chemotherapy drugs that can harm the heart. If you are at high risk for heart problems from chemo, this study may offer a way to reduce that risk.

NCT07254221Not yet recruiting· Phase 4
Rosuvastatin to protect heart during breast cancer chemo

This trial tests if taking rosuvastatin (a cholesterol-lowering pill) can help prevent heart damage from anthracycline chemotherapy in women with breast cancer. If you are about to start this type of chemo and have not used statins before, you may qualify.

Shiraz, Fars
NCT04332341Recruiting· Early Phase 1
Nicotinamide riboside during bone marrow transplant

This trial studies whether a supplement called nicotinamide riboside (a vitamin-like product) can be given safely during allogeneic bone marrow transplant. It may help researchers understand how well it works and how it affects recovery for people getting a donor transplant.

Cleveland, Ohio
NCT06425042Recruiting
Nicotinamide riboside with exercise for healthy aging

This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.

Santiago, Santiago Metropolitan
NCT06521307Not yet recruiting
Nicotinamide riboside for kidney protection during heart surgery

This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can help protect your kidneys during heart valve surgery. You may qualify if you are scheduled for this surgery and meet a few health requirements.

México
NCT06345443Enrolling by invitation
Nicotinamide riboside for blood vessel health

This trial tests a nutritional supplement (nicotinamide riboside) to see how it affects blood flow in healthy adults. It may help understand how to support vascular health as we age.

Rochester, Minnesota

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.